Get the Stockscreener App
10.03
7.22%
0.675
Tempest Therapeutics Inc stock is traded at $10.03, with a volume of 42,596.
It is up +7.22% in the last 24 hours and up +58.87% over the past month.
Tempest Therapeutics Inc is a late-stage develpment biotechnology company developing small molecule therapeutics to treat cancer through mechanisms that directly kill tumor cells and activate tumor-specific immunity. Its clinical-stage therapeutic product candidates are TPST-1120 and TPST-1495 which are clinical-stage molecules designed to inhibit their respective targets.
See More
Previous Close:
$9.35
Open:
$9.35
24h Volume:
42,596
Relative Volume:
0.34
Market Cap:
$44.51M
Revenue:
-
Net Income/Loss:
$-43.10M
P/E Ratio:
-1.0367
EPS:
-9.67
Net Cash Flow:
$-36.82M
1W Performance:
-4.80%
1M Performance:
+58.87%
6M Performance:
-10.37%
1Y Performance:
-47.18%
1-Day Range:
$9.35
$10.10
1-Week Range:
$9.0501
$10.76
52-Week Range:
$5.3495
$20.67
Tempest Therapeutics Inc Stock (TPST) Company Profile
Name
Tempest Therapeutics Inc
Sector
Industry
Phone
415-798-8589
Address
2000 SIERRA POINT PARKWAY, BRISBANE
Compare TPST with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
TPST
Tempest Therapeutics Inc
|
10.03 | 45.11M | 0 | -43.10M | -36.82M | -9.67 |
|
VRTX
Vertex Pharmaceuticals Inc
|
395.12 | 99.96B | 11.39B | 3.64B | 3.50B | 13.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
589.48 | 60.83B | 14.21B | 4.46B | 3.56B | 39.68 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
454.38 | 59.89B | 2.46B | -319.09M | -52.09M | -2.47 |
|
ARGX
Argen X Se Adr
|
660.00 | 40.47B | 3.06B | 1.28B | 447.35M | 21.30 |
|
ONC
Beone Medicines Ltd Adr
|
313.67 | 37.96B | 3.81B | -644.79M | -669.77M | -6.24 |
Tempest Therapeutics Inc Stock (TPST) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Apr-10-25 | Downgrade | H.C. Wainwright | Buy → Neutral |
| Apr-10-25 | Downgrade | Scotiabank | Sector Outperform → Sector Perform |
| Mar-14-24 | Initiated | Scotiabank | Sector Outperform |
| Feb-08-24 | Initiated | Jefferies | Buy |
Tempest Therapeutics Inc Stock (TPST) Latest News
Tempest Therapeutics Inc. Enters Reversal Setup in Weekly ChartsWeekly Risk Summary & Fast Moving Trade Plans - beatles.ru
Watch for Bullish Crossover in Tempest Therapeutics Inc.2025 Performance Recap & Community Shared Stock Ideas - classian.co.kr
Heatmap Data Shows High Activity in Tempest Therapeutics Inc. Sector2025 Stock Rankings & Weekly Top Performers Watchlists - newsimpact.co.kr
Analysts Spot Bullish Divergence in Tempest Therapeutics Inc.July 2025 Weekly Recap & Comprehensive Market Scan Insights - beatles.ru
Can swing trading help recover from Tempest Therapeutics Inc. lossesWeekly Trading Summary & Pattern Based Trade Signal System - Newser
Is Tempest Therapeutics Inc. trending in predictive chart modelsWeekly Trade Analysis & Free Expert Approved Momentum Trade Ideas - Newser
What data driven models say about Tempest Therapeutics Inc.’s future - Newser
Pattern recognition hints at Tempest Therapeutics Inc. upsideJuly 2025 Sector Moves & Safe Entry Point Alerts - Newser
Tempest Therapeutics Inc. stock outlook for YEARJuly 2025 Momentum & Free Expert Approved Momentum Trade Ideas - Newser
Using data tools to time your Tempest Therapeutics Inc. exitWeekly Investment Recap & Weekly Watchlist of Top Performers - Newser
What makes Tempest Therapeutics Inc. stock price move sharplyBull Run & Risk Controlled Swing Trade Alerts - Newser
What momentum shifts mean for Tempest Therapeutics Inc.Portfolio Gains Report & Daily Growth Stock Investment Tips - Newser
Using economic indicators to assess Tempest Therapeutics Inc. potentialMarket Movement Recap & Consistent Profit Trade Alerts - Newser
Quantitative breakdown of Tempest Therapeutics Inc. recent moveQuarterly Profit Report & AI Driven Price Forecasts - Newser
Tempest Therapeutics Inc. Inches Toward Key Resistance — Will It BreakJuly 2025 Drop Watch & Smart Investment Allocation Tips - 선데이타임즈
Tempest Therapeutics Inc. stock chart pattern explainedMarket Risk Analysis & Safe Capital Growth Trade Ideas - Newser
Can machine learning forecast Tempest Therapeutics Inc. recoveryEarnings Beat & Free Weekly Watchlist of Top Performers - Newser
Is Tempest Therapeutics Inc. a turnaround storyTrade Analysis Report & Technical Pattern Based Signals - kangso.co.kr
Exit strategy if you’re trapped in Tempest Therapeutics Inc.Market Risk Report & Community Trade Idea Sharing Platform - Newser
Top chart patterns to watch in Tempest Therapeutics Inc.Entry Point & Free Community Consensus Stock Picks - Newser
How Interest Rate Changes Impact Tempest Therapeutics Inc. Stock PerformanceQuarterly Earnings Report & Reliable Volume Spike Trade Alerts - Newser
Why Tempest Therapeutics Inc. stock attracts strong analyst attentionMarket Performance Recap & Smart Swing Trading Alerts - Newser
Custom watchlist performance reports with Tempest Therapeutics Inc.2025 Winners & Losers & Growth Focused Stock Pick Reports - Newser
Real time alert setup for Tempest Therapeutics Inc. performanceTrade Ideas & High Accuracy Swing Entry Alerts - Newser
How institutional ownership impacts Tempest Therapeutics Inc. stockEarnings Summary Report & Daily Oversold Stock Bounce Ideas - Newser
Analyzing drawdowns of Tempest Therapeutics Inc. with statistical toolsGDP Growth & Stock Portfolio Risk Control - Newser
Is Tempest Therapeutics Inc. forming a reversal patternWeekly Market Report & Technical Pattern Based Signals - Newser
Tempest Therapeutics Inc. Reversal Rally May Surprise Bears2025 Key Lessons & Free Weekly Chart Analysis and Trade Guides - beatles.ru
Is Tempest Therapeutics Inc. stock a growth or value playAnalyst Upgrade & Free High Accuracy Swing Entry Alerts - Newser
Tempest Therapeutics Inc. Building a Base Near SupportAnalyst Upgrade & Entry and Exit Point Strategies - newsyoung.net
Technical analysis overview for Tempest Therapeutics Inc. stockJuly 2025 Short Interest & Low Risk Growth Stock Ideas - Newser
Is Tempest Therapeutics Inc. stock bottoming out2025 Market Outlook & Fast Momentum Stock Entry Tips - Newser
Predicting Tempest Therapeutics Inc. trend using moving averagesFree Entry Alert With Low Drawdown Strategy - Newser
Is Tempest Therapeutics Inc. a play on infrastructure spendingBottom Formation Alert - thegnnews.com
Tempest Therapeutics Inc Stock (TPST) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.94%
1.72%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):